Selection criteria for antirejection therapy.
Wilmink
J M
JM
Department of Nephrology, Academic Medical Centre, Amsterdam, The Netherlands.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006084:Graft Rejection; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008875:Middle Aged; D016853:Muromonab-CD3
D000305:Adrenal Cortex Hormones; D000906:Antibodies; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3